Spanish company looking for health institutions interested in acquiring a license to use a software developed for the integral management and decision-making support of tumour boards in hospitals.

TechnologyŠpanielskoTOES20210803001
Offers
Summary: 
A Spanish company has developed a solution for an integral management and decision-making support of tumour boards in hospitals, that includes centralisation of all information in one place, patient follow-up, decision support system using artificial intelligence and machine learning, patient application and analytics tools to follow-up the board’s activities. The company is looking for health institutions treating cancer patients interested in acquiring the license to use the technology.
Description: 
There is a growing increase on the complexity of cancer treatment, with the use of biomarkers, image studies and information stored in different services of the hospital. It is very important the role of multidisciplinary medical teams capable of taking therapeutic decisions stemming from the evaluation of different medical information sources. Current workload in the hospitals does not allow to hold the necessary number of tumour board meetings. The preparation of such meetings requires, in average, between 15 and 20 hours of work for each meeting. To provide support for the professionals engaged in tumour boards, a Spanish software company has developed a solution to facilitate their work. The technology is focused on the treatment of lung cancer, but it can be extended to other cancers or other diseases. Key features description: Tumour board application: The main goals of this module are reducing the administrative burden; homogenize and structure the available data and the outcomes from the decision-making; assist in the decision-making process; offer usable and intuitive interfaces tailored for each phase of the process, allow for session virtualisation and involving the patient in the process. Patient follow-up/Timeline: This solution allows to perform a follow-up of all patients. All the healthcare professionals involved in a case will be able to follow the case since the first diagnosis until the process finalizes. Levels of access to information are fully customizable. Decision-support system: The product has an artificial intelligence-based decision-support system that will emit treatment recommendation based on the most recent clinical evidence and clinical guides. All the patient’s clinical variables are assessed using the criteria recommended in the clinical guide. The system will emit a series of recommendations to the healthcare professional. The system stores the studied cases, the decisions taken, and the patient’s outcomes and evaluates the actions performed. Patient homecare: This module tries to bring healthcare assistance into the patient’s home by adding new means of communication between healthcare professionals and patients. New information can be brought up by means of Patient Reported Outcomes (PROMs) and Patient Reported Experiences (PREMS). That way, members of the tumour board can employ the information reported by the patient (stress levels, physical activity…) to take decisions regarding the patient’s treatment. Consumer-grade smart wearables can be linked to the system. It also includes an app for the patient that allows to measure the family’s resilience levels and their strength to face the patient’s journey. Finally, the app will emit health style recommendations to the patients and their families regarding healthy eating, exercising and hygienic habits to avoid complications during the treatment. Dashboards and indicators: This solution incorporates several data analytics tools to access all the necessary information in real time to support the decision processes. Analytical indicators to offer an aggregated and retrospective vision to detect patterns, assess the different phases in the patient’s processes and obtain new insights from available information. All this information will be provided graphically and on-demand. Finally, several key performance indicators are also present to have a quantitative measure of the efficiency of of the processes. All indicators can be customized. The company is looking for health institutions treating patients with cancer interested in improving the management of their tumour board meetings by means of a tool capable of centralizing information, support decision-making processes and workflow optimization. By buying a license to use this solution, the company would handle all the installation and integration of the software into the partner’s system and train its personnel in using the tool.
Type (e.g. company, R&D institution…), field of industry and Role of Partner Sought: 
The company is looking to partner with health institutions (either public or private) treating patients with cancer, interested in improving the management of their tumour board meetings by means of a tool capable of centralizing information, support decision-making processes and workflow optimization. By buying a license to use this solution, the company would handle all the installation and integration of the software into the partner’s system and train its personnel in using their tool.
Stage of Development: 
Already on the market
IPR Status: 
Copyright
Comments Regarding IPR Status: 
Applied for copyright in June 2021. Copyright grant expected by December 2021
External code: 
TOES20210803001